Heartnet utilizes electromagnetic protocols and digital twins to authenticate drug provenance, ensuring that consumers can verify the authenticity of medications. The platform addresses the issue of counterfeit drugs, which constitute an estimated 30%-40% of the pharmaceutical market in Nigeria, by providing a track-and-trace solution that enhances supply chain visibility.
Funding
$120K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Counterfeit drugs represent a significant portion of the pharmaceutical market, particularly in regions like Nigeria, leading to health risks and undermining trust in the supply chain. Existing solutions often struggle to keep pace with counterfeiters, who continuously adapt their methods. This necessitates a robust and adaptable system for verifying drug authenticity.
Solution
Heartnet offers a track-and-trace solution that combines electromagnetic protocols and digital twins to authenticate drug provenance, providing consumers with a means to verify the authenticity of medications. The system creates an immutable record of a drug's journey through the supply chain, from origin to consumer. By enabling consumers to validate the provenance of their medications, Heartnet helps manufacturers protect their brand and ensures that patients receive genuine drugs. The platform aims to enhance supply chain visibility and reduce the prevalence of counterfeit drugs.
Target Audience
The primary target audience includes pharmaceutical manufacturers seeking to protect their brand, and consumers who want to ensure the authenticity and safety of their medications.
Features
- Mobile app for end-users to confirm proof of origin and identify counterfeit drugs.
- Data backend that is immutable and carries provenance data from origination through the supply chain.
- Track-and-trace system providing authentication and proof of origin.
- Combines electromagnetic protocol and digital twins to distinguish authentic drugs from counterfeits.